PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
New Jersey MedicaidMedicaid · Coverage · Pharmacy · NJLow impact

Newsletter Vol. 5, No. 54

Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

New manufacturers have been added to the PAAD Drug Rebate Program's approved labeler code list. This affects pharmaceutical billing and reimbursement for aged and disabled patients in New Jersey's prescription assistance program.

Get alerts when payers change rules like this one

We check New Jersey Medicaid and other payers every day and email you when a change matches your specialty and state.

Get New Jersey Medicaid alertsPolicy Monitoring is free. No card required.

What to do

Action · 2 steps
01Review the updated APPENDIX F manufacturers' labeler code list at https://www.njmmis.com/documentDownload.aspx?document=5-54.pdf to identify any new pharmaceutical manufacturers that may affect prescription billing for PAAD-eligible patients.
02Pharmacy billing staff should verify coverage for medications from newly added manufacturers.

Original notice

Newsletter Vol. 5, No. 54
njmmis.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account